STOCK TITAN

Dolby Laboratories (DLB) insider plans $83,630 sale of common shares

(Neutral)
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Dolby Laboratories, Inc. insider Ryan H. Nicholson filed to sell common stock through Morgan Stanley Smith Barney LLC. The notice covers 1,348 common shares, with an indicated aggregate value of $83,630.05, to be sold on or after 08/10/2026 on the NYSE. The shares relate to prior restricted stock awards granted in 2020 and 2021. Over the past three months, Nicholson has already sold 357 shares for proceeds of $21,644.91.

Positive

  • None.

Negative

  • None.
Shares to be sold 1,348 shares Common stock covered by the notice to be sold on or after 08/10/2026
Aggregate value of planned sale $83,630.05 Value associated with 1,348 Dolby common shares in the planned transaction
Shares sold in past 3 months 357 shares Common shares sold on 08/04/2026 by Ryan H. Nicholson
Proceeds from recent sale $21,644.91 Value of 357 Dolby common shares sold on 08/04/2026
Restricted stock grant 2020 (portion) 510 shares Restricted stock listed with a 12/15/2020 grant date
Restricted stock grant 2020 (additional) 327 shares Additional restricted stock listed with a 12/15/2020 grant date
Restricted stock grant 2021 511 shares Restricted stock listed with a 12/15/2021 grant date
Restricted Stock financial
"Common | 12/15/2020 | Restricted Stock | Issuer"
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
Securities To Be Sold regulatory
"144: Securities To Be Sold"
Securities Sold During The Past 3 Months regulatory
"144: Securities Sold During The Past 3 Months"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What does Dolby Laboratories (DLB) insider Ryan Nicholson plan to sell under this notice?

Ryan H. Nicholson plans to sell 1,348 shares of Dolby Laboratories common stock. The filing lists these shares with an aggregate value of $83,630.05, to be sold on or after 08/10/2026 through Morgan Stanley Smith Barney LLC on the NYSE.

What type of Dolby (DLB) awards are involved in Ryan Nicholson’s planned stock sale?

The planned sale involves shares from restricted stock awards. These awards were granted on 12/15/2020 and 12/15/2021, with individual components of 510, 327, and 511 shares listed as their sources.

Has Dolby (DLB) insider Ryan Nicholson sold any shares in the last three months?

Yes. In the last three months, Ryan H. Nicholson sold 357 shares of Dolby common stock. The sale occurred on 08/04/2026 and generated proceeds of $21,644.91, according to the recent Form 144 information.

Which broker is handling the planned Dolby (DLB) stock sale for Ryan Nicholson?

The planned sale is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services. The broker’s address is listed as 1 New York Plaza, 8th Floor, New York, NY 10004, acting for Nicholson’s Dolby common stock transaction.

On which exchange are Ryan Nicholson’s Dolby (DLB) shares expected to be sold?

The shares are indicated to be sold on the NYSE. The Form 144 details common stock of Dolby Laboratories with a proposed sale date of 08/10/2026, to be transacted on the New York Stock Exchange through the named broker.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature